Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Invested Capital (2016 - 2025)

United Therapeutics (UTHR) has disclosed Return on Invested Capital for 16 consecutive years, with 0.17% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital rose 1.0% to 0.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.17% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.17% for FY2025, 1.0% up from the prior year.
  • Return on Invested Capital hit 0.17% in Q4 2025 for United Therapeutics, up from 0.17% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.18% in Q1 2022 to a low of 0.09% in Q1 2021.
  • Historically, Return on Invested Capital has averaged 0.15% across 5 years, with a median of 0.16% in 2024.
  • Biggest five-year swings in Return on Invested Capital: decreased -8bps in 2021 and later rose 9bps in 2022.
  • Year by year, Return on Invested Capital stood at 0.11% in 2021, then surged by 40bps to 0.16% in 2022, then decreased by -8bps to 0.15% in 2023, then increased by 9bps to 0.16% in 2024, then increased by 5bps to 0.17% in 2025.
  • Business Quant data shows Return on Invested Capital for UTHR at 0.17% in Q4 2025, 0.17% in Q3 2025, and 0.16% in Q2 2025.